TARS
Tarsus Pharmaceuticals
$60.12
+$1.46 (+2.49%)Jul 27, 2026
Key metrics
The numbers that frame TARS today
- Market cap
- $2.59B
- P/E (TTM)
- -53.6
- EV / FCF
- -81.1
- Gross margin
- 93.5%
- EV / Sales
- 4.8
- ROIC
- -9.7%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $38.51
- 52wk High
- $85.25
Growth
Revenue and earnings trend for TARS
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about TARS
Is Tarsus Pharmaceuticals a good buy?
Hold. Tarsus Pharmaceuticals has strong momentum, but weak quality makes the setup mixed. Growth looks excellent, which supports the long-term business case. We think Tarsus Pharmaceuticals is selling at a high price.
What is the market capitalization of TARS?
Tarsus Pharmaceuticals's market capitalization is $2.59B.
What is the P/E ratio for TARS stock?
Tarsus Pharmaceuticals's current P/E ratio is -53.6.
What is the 52-week high for TARS stock?
The 52-week high for Tarsus Pharmaceuticals is $85.25. The current close of $60.12 is 29.5% below that high.
What is the 52-week low for TARS stock?
The 52-week low for Tarsus Pharmaceuticals is $38.51. The current close of $60.12 is 56.1% above that low.
Does TARS stock pay dividends?
Tarsus Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for TARS?
Tarsus Pharmaceuticals's Debt / Equity ratio is 0.21.